STRUCTURAL BIOINFORMATICS OF HAEMOPHILUS INFLUENZAE MACRODOMAIN TER PROTEIN (MATP): IMPLICATIONS IN BIOCHEMISTRY, HEMATOLOGY AND DRUG DEVELOPMENT
Main Article Content
Keywords
MatP protein, HI1647 gene, Macrodomain Ter, Chromosome segregation, Homology modeling
Abstract
Introduction: Haemophilus influenzae is a significant pathogen implicated in respiratory and systemic infections, particularly among vulnerable populations. The MatP protein (HI1647 gene product) plays a critical role in chromosome segregation and bacterial viability, making it a potential therapeutic target. This study aimed to model the 3D structure of the MatP protein and correlate its relevance with clinical and hematological parameters in infected patients.
Objective: To model the three-dimensional structure of the structurally conserved MatP protein (HI1647) of Haemophilus influenzae using homology modeling and to investigate its potential as a novel antimicrobial drug target by correlating its role in bacterial viability with clinical and hematological indicators of infection severity in affected patients.
Methodology: The MatP amino acid sequence was retrieved from NCBI, and a BLASTp search was performed against the PDB. The E. coli MatP/MatS complex (PDB ID: 3VEA) was selected as a template for homology modeling using MODELLER 9.10. The best model was validated using PROCHECK. Clinical and laboratory data, including CRP, ALT, LDH, IL-6, WBC count, neutrophils, platelets, and hemoglobin levels, were collected from confirmed H. influenzae cases.
Results: The modeled HI1647 MatP protein showed high structural quality with >90% residues in the most favored regions of the Ramachandran plot. Clinically, infected patients exhibited elevated CRP, IL-6, and neutrophil levels, along with altered platelet counts.
Conclusion: The study confirms the structural conservation of the MatP protein and highlights its potential as a drug target. Hematological parameters provide valuable indicators of infection severity, supporting an integrated approach to diagnosis and therapeutic development in H. influenzae infections.
References
2. Kaushik V, Tiwari M, Joshi R, Tiwari V. Therapeutic strategies against potential antibiofilm targets of multidrug‐resistant Acinetobacter baumannii. Journal of cellular physiology. 2022 Apr;237(4):2045-63.
3. Leslie Smith DN, APRN-CNS AO, BMTCN Susan Smith DN. Hematological and Immune Disorders. Sole's Introduction to Critical Care Nursing-E-Book: Sole's Introduction to Critical Care Nursing-E-Book. 2024 Jun 21:451.
4. Das J, Bhui U, Chowdhary S, Sarkar S, Ghoshal IK, Nayak S, Bishayee R, Khurana N, Kumar B, Sharma N. Biomarkers Unveiling Neurodegeneration: Keys to Progression and Therapeutic Insights. Indian Journal of Pharmaceutical Education and Research. 2025 Feb 4;59(1s):s1-5.
5. High NJ. Haemophilus influenzae. InMolecular Medical Microbiology 2002 Jan 1 (pp. 1967-1988). Academic Press.
6. Nash AA, Dalziel RG, Fitzgerald JR. Mims' pathogenesis of infectious disease. Academic Press; 2015 Jan 24.
7. Tarín-Pelló A, Suay-García B, Pérez-Gracia MT. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal. Expert Review of Anti-infective Therapy. 2022 Aug 3;20(8):1095-108.
8. Shahbaaz M, ImtaiyazHassan MD, Ahmad F. Functional annotation of conserved hypothetical proteins from Haemophilus influenzae Rd KW20. PloS one. 2013 Dec 31;8(12):e84263.
9. Puranik S, Acajjaoui S, Conn S, Costa L, Conn V, Vial A, Marcellin R, Melzer R, Brown E, Hart D, Theißen G. Structural basis for the oligomerization of the MADS domain transcription factor SEPALLATA3 in Arabidopsis. The Plant Cell. 2014 Sep 1;26(9):3603-15.
10. Davidson AL, Dassa E, Orelle C, Chen J. Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiology and molecular biology reviews. 2008 Jun;72(2):317-64.
11. Han Q, Wen X, Wang L, Han X, Shen Y, Cao J, Peng Q, Xu J, Zhao L, He J, Yuan H. Role of hematological parameters in the diagnosis of influenza virus infection in patients with respiratory tract infection symptoms. Journal of clinical laboratory analysis. 2020 May;34(5):e23191.
12. Gulhar R, Ashraf MA, Jialal I. Physiology, acute phase reactants.
13. Hannoodee S, Nasuruddin DN. Acute inflammatory response. InStatPearls [Internet] 2024 Jun 8. StatPearls Publishing.
14. Qing X, Yin Lee X, De Raeymaeker J, RH Tame J, YJ Zhang K, De Maeyer M, RD Voet A. Pharmacophore modeling: advances, limitations, and current utility in drug discovery. Journal of Receptor, Ligand and Channel Research. 2014 Nov 11:81-92.
15. Huang X, Li G. Antimicrobial peptides and cell-penetrating peptides: non-antibiotic membrane-targeting strategies against bacterial infections. Infection and drug resistance. 2023 Dec 31:1203-19.
16. Mercier R, Petit MA, Schbath S, Robin S, El Karoui M, Boccard F, Espéli O. The MatP/matS site-specific system organizes the terminus region of the E. coli chromosome into a macrodomain. Cell. 2008 Oct 31;135(3):475-85.